Unlock stock picks and a broker-level newsfeed that powers Wall Street.
OTC Markets OTCPK USD

Zicix Corporation (ZICX)

Compare
0.0004
-0.0002
(-33.33%)
At close: April 4 at 2:30:12 PM EDT
Loading Chart for ZICX
  • Previous Close 0.0006
  • Open 0.0005
  • Bid 0.0004 x --
  • Ask 0.0005 x --
  • Day's Range 0.0004 - 0.0005
  • 52 Week Range 0.0004 - 0.0015
  • Volume 2,930,000
  • Avg. Volume 322,767
  • Market Cap (intraday) 4.996M
  • Beta (5Y Monthly) 1.43
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Zicix Corporation, through its subsidiary, Texas Mobile Health, Inc., provides diagnostic medical imaging services in Houston, Texas. It offers cardiac diagnostic services, including echocardiogram, stress testing, carotid ultrasound, and halter and event monitoring services; medical services, such as general medical care, medical care for home health patients, general and immigration physicals, weight reduction, cold laser pain relief treatment, physical therapy, and anti-aging treatment; and MRI, CT, and X-Ray services. The company was formerly known as Bederra Corporation and changed its name to Zicix Corporation on February 8, 2011. Zicix Corporation was founded in 1979 and is based in Houston, Texas.

www.zicixgroup.com

2

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ZICX

View More

Performance Overview: ZICX

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ZICX
0.00%
S&P 500 (^GSPC)
13.73%

1-Year Return

ZICX
39.39%
S&P 500 (^GSPC)
1.42%

3-Year Return

ZICX
80.95%
S&P 500 (^GSPC)
10.72%

5-Year Return

ZICX
94.87%
S&P 500 (^GSPC)
103.89%

Compare To: ZICX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ZICX

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    5.00M

  • Enterprise Value

    5.00M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -53.38k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    77

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: ZICX

View More

Company Insights: ZICX

Research Reports: ZICX

View More

People Also Watch